Bonum Health Plans to Attend Pharmaceutical Developmental Service (PDS) Conference

Bonum Health is gearing up to exhibit at the 2020 Pharmaceutical Development Service (PDS) Super-Conference. This event is set to take place in Orlando, FL, at the Rosen Shingle Creek resort on February 27-29th. By attending PDS, Bonum Health intends to showcase the newly released Bonum Health Hub to other industry innovators and Independent pharmacies, along with unveiling new features and benefits. The PDS conference is made up of like-minded business owners in the pharmaceutical industry working to transform the already disrupted market of independent pharmacies.

One of the key features of Bonum Health’s display will be a completely built Bonum Health Hub model at the conference for attendees to experience this one of a kind, innovation. In addition to the Hub, Bonum will be displaying the functions of the mobile and web telehealth application. By innovating a modern method for patients to track and access their personal health records, and giving patients a more time efficient and affordable access to primary care consultations, Bonum Health is re-imagining the industry of healthcare while also reviving independent pharmacies by bringing patients back in their doors and increasing prescriptions.

About Bonum Health. Bonum Health is a digital health technology company, a wholly owned subsidiary of Trxade, connecting patients to board-certified medical care at any time, and from anywhere by the Bonum Health mobile app and website portal or by visiting Bonum Health Hubs planned for select independent pharmacy locations. Bonum Health is a convenient and affordable alternative for patients needing non-emergency care without the inconvenience and expense of urgent care visits.

To learn more, visit www.bonumhealth.com.

About Trxade Group, Inc. Trxade Group, Inc.’s (OTCQB: MEDS) (“Trxade” or the “Company”),  headquartered in Tampa, Florida, is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, accessories and services. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; the Trxade B2B trading platform with 11,000 registered pharmacies, licensed virtual Wholesale and Mail Order Pharmacy capabilities including DelivMeds, as well as the newly acquired assets of Bonum Health.

For additional information, please visit us at www.trxade.com, www.delivmeds.com.

 

Forward-Looking Statements

Certain statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “will,” “would” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Certain risks and uncertainties applicable to us and our operations are described in the “Risk Factors” sections of our most recent annual and quarterly reports and in other reports we have filed with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov.

Investors Contact:

Simonne Valdez

IR@trxade.com

800-261-0281